News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Loose Christopher R.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/27/2023 |
4
| Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 1,390 shares
@ $0.5, valued at
$695 Sold 1,329 shares
@ $0.51, valued at
$677.8 |
|
07/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/19/2023 |
4
| Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 1,415 shares
@ $0.67, valued at
$948.1 Sold 1,484 shares
@ $0.56, valued at
$831 |
|
07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/17/2023 |
4
| Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 1,329 shares
@ $0.39, valued at
$518.3 Sold 906 shares
@ $0.59, valued at
$534.5 |
|
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/13/2023 |
4
| Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 1,363 shares
@ $0.37, valued at
$504.3 Sold 1,335 shares
@ $0.39, valued at
$520.7 |
|
|
|
|